The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: The Veterans Affairs HDL Intervention Trial (VA-HIT)
E. Shyong Tai, Dorothea Collins, Sander J. Robins, John J. O’Connor Jr., Hanna E. Bloomfield, Jose M. Ordovas, Ernst J. Schaefer, Margaret E. BrousseauVolume:
187
Year:
2006
Language:
english
DOI:
10.1016/j.atherosclerosis.2005.08.034
File:
PDF, 189 KB
english, 2006